Ask AI

CCO Independent Conference Highlights From the 2025 ASCO Annual Meeting

Review slidesets, on-demand webcasts, an expert analysis, and a podcast of key data from the 2025 ASCO Annual Meeting.

Share

Program Content

Activities

ASCO 2025 Preview
An Expert’s Guide to ASCO 2025: Preview of the Top Abstracts
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: May 29, 2025

Expires: November 28, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Breast Cancer: Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc, Gilead Sciences, Inc., Lilly, Novartis Pharmaceuticals Corporation, and Stemline Therapeutics, Inc.
Lung Cancer: Supported by educational grants from AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi Sankyo, Inc, Genentech, a member of the Roche Group, and PharmaMar.
Lymphoma and Leukemia: Supported by an educational grant from Novartis Pharmaceuticals Corporation.
Genitourinary Cancer: Supported by an educational grant from Astellas.
Gastrointestinal Cancer: Supported by educational grants from Daiichi Sankyo, Inc. and Genentech, a member of the Roche Group.

Astellas

AstraZeneca

Boehringer Ingelheim Pharmaceuticals, Inc.

Daiichi Sankyo, Inc.

Genentech, a member of the Roche Group

Genentech, a member of the Roche Group

Gilead Sciences, Inc.

Lilly

Novartis Pharmaceuticals Corporation

PharmaMar

Stemline Therapeutics, Inc.